Diethanolamine (DEA) has been a workhorse of the personal care ingredient industry for decades. Behind the names Cocamide DEA, Lauramide DEA, and Cocamide DIPA on shampoo and body wash labels is a class of multifunctional surfactants that deliver foam, viscosity, and skin feel in a single ingredient - and almost all of them trace their origin to diethanolamine reacting with a fatty acid.
Over the past decade, regulatory changes in the EU and California have narrowed the conditions under which free DEA and its derivatives can be used in consumer products, driving significant reformulation activity. Yet DEA-derived ingredients remain commercially active in many markets, and DEA itself continues to be used as a pH adjuster and processing aid in a range of personal care manufacturing processes that never appear on a finished-product label.
This guide is written for cosmetic formulators, product developers, and procurement teams who need an accurate, up-to-date picture of where DEA fits in personal care - what it does well, where its regulatory limits apply, and how to make sound substitution decisions when required. For DEA physicochemical specifications, see our Diethanolamine product page.
🧪 What Diethanolamine Does in Personal Care
DEA appears in personal care products in two distinct forms, each with a different function and a different regulatory footprint.
🛁 Cocamide DEA: The Most Important DEA Derivative
Cocamide DEA (CAS 61791-31-9) is produced by condensing coconut fatty acids with diethanolamine at a roughly 1:2 molar ratio (fatty acid : DEA), yielding a fatty acid diethanolamide. Because DEA is a secondary amine with two hydroxyethyl groups, the reaction produces a diamide structure - this is the chemistry that gives cocamide DEA its distinctive viscosity-building and foam-enhancing performance.
| INCI Name | Cocamide DEA |
| CAS Number | 61791-31-9 |
| Surfactant Class | Non-ionic, fatty acid diethanolamide |
| Appearance | Amber to dark amber viscous liquid |
| HLB Value | ~10–12 (hydrophilic side) |
| Typical Use Level | 1–5% in finished formulation |
| Physical Form at 20 °C | Liquid (does not solidify at ambient, unlike cocamide MEA) |
🫧 Why Cocamide DEA Became the Industry Standard
Cocamide DEA dominated the alkanolamide market from the 1960s through the 2000s for straightforward performance reasons: it is highly effective at its two main functions, easy to handle as a liquid, and inexpensive relative to the performance it delivers.
At 2–5% in a SLES-based shampoo base, cocamide DEA increases foam volume, improves foam density ("creaminess"), and extends foam stability - the key sensory attributes that consumers associate with effective cleansing. It inserts into anionic surfactant micelles, increasing their packing efficiency and stabilising foam lamellae.
Cocamide DEA is a more effective viscosity builder than cocamide MEA at equivalent concentrations. In NaCl-thickened SLES systems, cocamide DEA broadens and enhances the salt-thickening curve, allowing formulators to achieve target viscosity at lower NaCl concentration. This gives more flexibility in formulation pH and preservative compatibility.
The fatty acid chains in cocamide DEA deposit a thin conditioning film on skin and hair surfaces during rinse-off, contributing to post-wash softness and reduced skin tightness. This mild conditioning effect is a key part of the sensory profile of many mid-range shampoos and body wash products.
Unlike cocamide MEA, which is a solid at ambient temperature requiring pre-melting before addition, cocamide DEA is a liquid across the full range of normal manufacturing temperatures. It can be added directly to the surfactant blend without heating, simplifying production and reducing cycle time.
🧴 Other DEA Derivatives Used in Personal Care
Beyond cocamide DEA, several other DEA-derived ingredients appear across personal care product categories:
| INCI Name | Source Fatty Acid | Primary Function | Typical Category |
|---|---|---|---|
| Cocamide DEA | Coconut fatty acids (C8–C18) | Foam boost, viscosity, conditioning | Shampoo, body wash, dish liquid |
| Lauramide DEA | Lauric acid (C12) | Foam boost (fast-rising), viscosity | Shampoo, hand soap, bubble bath |
| Oleamide DEA | Oleic acid (C18:1) | Emollient, conditioner, gentle foam | Shower gel, bath oil, shaving cream |
| Linoleamide DEA | Linoleic acid (C18:2) | Emollient, moisturising surfactant | Skin cleansers, body wash |
| Myristamide DEA | Myristic acid (C14) | Viscosity building, stable foam | Shampoo, cleansers |
🌍 Regulatory Status: What Is and Isn't Permitted
The regulatory landscape for DEA in personal care has tightened considerably over the past fifteen years. Formulators working across multiple markets need to understand the specific restrictions at each level - free DEA vs derivatives, leave-on vs rinse-off, general population vs children.
🇪🇺 EU Cosmetics Regulation (EC 1223/2009)
Prohibited. Free DEA must not be present as an intentionally added ingredient in leave-on cosmetics under any concentration.
Maximum 5%. Must not be combined with nitrosating systems. Final product must not contain N-nitrosamines above 50 µg/kg.
Maximum 10%. Same nitrosating agent exclusion requirement. Prohibited in products intended for children under 3 years of age.
Prohibited. The restriction applies to cocamide DEA used in any leave-on product category, including body lotions, facial moisturisers, and hair conditioners.
🇺🇸 United States
The FDA has issued a consumer advisory on DEA-containing shampoos and hair products but has not promulgated a maximum concentration limit at the federal level. Cocamide DEA was listed under California Proposition 65 as a known carcinogen in 2012 - the first major DEA derivative to receive this designation. Products sold in California containing cocamide DEA above the established No Significant Risk Level (NSRL) may require a Prop 65 warning. Brands selling into the California market should obtain legal guidance on their specific formulations.
🌏 Asia-Pacific Markets
China (NMPA), ASEAN, Japan, and South Korea generally permit cocamide DEA in rinse-off products at concentrations consistent with EU limits, with the same N-nitrosamine controls (≤50 µg/kg in finished product). None of these markets impose a leave-on prohibition as strict as the EU's, but formulating to EU standards provides a single global specification that satisfies the most stringent requirements across all markets simultaneously.
🔬 Formulation Guidance for DEA-Containing Products
For formulators who are continuing to use cocamide DEA in rinse-off formulations within permitted concentration limits, the following practices are required for regulatory compliance and product safety.
Before finalising any cocamide DEA-containing formulation, screen every other ingredient for nitrosating activity. The primary risk compounds are bronopol (2-bromo-2-nitropropane-1,3-diol), DMDM hydantoin, imidazolidinyl urea, and diazolidinyl urea. Replace any of these with a non-nitrosating preservative system - phenoxyethanol/ethylhexylglycerin, sodium benzoate/potassium sorbate, or caprylyl glycol-based systems. This is not optional; it is a regulatory requirement under EU Cosmetics Regulation and best practice globally.
EU Cosmetics Regulation requires that finished products contain ≤50 µg/kg of N-nitrosamines. This should be confirmed by analytical testing (GC-TEA method or equivalent) at product launch and periodically during the product's commercial life. N-nitrosamine content can increase during storage, particularly at elevated temperatures - include testing at accelerated stability conditions (40 °C / 75% RH, 12 weeks) as part of your stability programme.
N-nitrosamine formation rates increase at lower pH. Maintaining formulation pH above 5.5 reduces the risk of in-situ nitrosation if trace nitrosating contaminants are present. For shampoos and body washes, a target pH of 5.5–6.5 is optimal for both skin compatibility and nitrosamine risk minimisation. Avoid formulations with pH below 4.5 where DEA derivatives are present.
Commercial cocamide DEA products vary significantly in free DEA content - the unreacted amine present after the amidation reaction. Free DEA is what forms NDELA; the amide itself is far less reactive. Request a CoA showing free DEA content and set an internal specification of ≤1.0% free DEA for personal care grades. Suppliers producing to higher-quality 1:1 molar ratio amidation processes typically achieve free DEA below 0.5%.
For any EU cosmetic containing free DEA (rinse-off, ≤5%) or cocamide DEA (rinse-off, ≤10%), the product safety assessment report (CPSR) must explicitly address the nitrosamine risk - confirming absence of nitrosating agents, confirming N-nitrosamine test results below 50 µg/kg, and confirming the product is not intended for children under 3 (for cocamide DEA). Ensure the Responsible Person has reviewed and signed off on these specific points. Regulators increasingly scrutinise DEA-containing product CPSRs.
🔄 Substituting DEA Derivatives: A Practical Guide
For formulators moving away from cocamide DEA - either due to regulatory requirements, brand positioning, or customer demand - the substitution landscape is well established. Cocamide MEA is the primary drop-in alternative, but the substitution is not always a clean 1:1 swap.
Cocamide DEA → Cocamide MEA
| Parameter | Cocamide DEA | Cocamide MEA | Adjustment Needed |
|---|---|---|---|
| Physical form | Liquid at ambient | Solid/waxy (mp 70–85 °C) | Pre-melt MEA before addition; adjust manufacturing process |
| Foam volume | Very good | Good | Increase MEA level to 110–130% of original DEA level |
| Foam texture | Creamy, dense | Voluminous, slightly less creamy | May require co-surfactant adjustment (e.g., add CAPB) |
| Viscosity contribution | Strong | Moderate | Adjust NaCl concentration (typically +0.3–0.5%) to recover viscosity |
| Regulatory status (EU) | Max 10% rinse-off only; prohibited leave-on; child product restriction | No leave-on restriction; no child product restriction | ✅ Regulatory advantage for MEA |
| Cost (relative) | Lower per kg | Slightly higher per kg | Usually offset by simplified compliance documentation |
Starting point: 3% cocamide DEA in a standard SLES/CAPB base at pH 6.0. Substitution approach: (1) Replace cocamide DEA with 3.5% cocamide MEA (add pre-melted to 70 °C surfactant blend); (2) Adjust NaCl from base level upward in 0.2% increments until target viscosity (3,000–6,000 mPa·s at 25 °C) is achieved; (3) Re-check pH and adjust with citric acid if needed; (4) Confirm foam profile by cylinder shake test and consumer panel. In most SLES bases, this substitution is achieved with minimal iteration. For full details on cocamide MEA formulation, see our article: Cocamide MEA: What It Is, How It's Made from Monoethanolamine & Applications.
Other Substitution Options
For formulators who require alternatives beyond cocamide MEA - for example, in natural or organic-positioned products where all alkanolamide-derived ingredients are restricted - the following alternatives offer different performance trade-offs:
- 🌿 Gluconamides (e.g., lauryl glucoside, coco glucoside) - natural-derived, biodegradable foam boosters with good tolerability; lower viscosity-building efficacy than DEA amides; more expensive
- 🧴 Betaines (cocamidopropyl betaine, CAPB) - amphoteric surfactants that boost foam and improve mildness; do not build viscosity through NaCl synergy but improve salt curve in combination; already in most shampoo bases as co-surfactant
- 🌾 Amine oxides (lauramine oxide) - excellent foam boosters and viscosity builders; compatible with anionic surfactants; not derived from DEA but check clean beauty restrictions, as amine oxides have their own label concerns in some markets
- 🔬 PEG-7 glyceryl cocoate or PEG-5 cocoamide - alternative conditioning and foam-modifying agents; higher cost; not suitable for sulfate-free positioning due to PEG chains
❓ Frequently Asked Questions
📝 Summary
Diethanolamine's role in personal care is primarily as the raw material for a family of fatty acid amide surfactants - most importantly cocamide DEA - that have provided foam, viscosity, and conditioning to rinse-off products for over half a century. Regulatory restrictions in the EU and California have narrowed the conditions of use and increased the compliance burden for DEA-derived ingredients, without eliminating them from the market.
For formulators, the decision between continuing with cocamide DEA (within permitted conditions) or substituting with cocamide MEA (cleaner regulatory path) is primarily a business decision about compliance simplicity and brand positioning rather than a performance decision. Cocamide MEA can replicate cocamide DEA's core functions in most SLES-based systems with modest formulation adjustment. For baby products and leave-on applications, cocamide MEA or non-alkanolamide alternatives are the only compliant choices in the EU market.
Sinolook Chemical supplies diethanolamine (DEA 99%) and monoethanolamine (MEA 99%, DEA ≤0.5%) for personal care amide production. Both grades are available with full CoA, SDS, and REACH documentation. For reformulation support from cocamide DEA to cocamide MEA, our technical team can assist with raw material specification and quality documentation.
